TY - JOUR
T1 - Prostatic intraepithelial neoplasia
T2 - Recent advances
AU - Ayala, Alberto G.
AU - Ro, Jae Y.
N1 - Funding Information:
Conflicts of interest: M. Karam is employed as a fellow-in-training at the University of Michigan. has received research support from NIH grant #2KL2TR000434, has received support from NIH grant #UL1RR024986, and receives support from the University of Michigan Food Allergy Center. He has received honoraria for speaking for Nutricia and is a member of their specialty advisory board. He is an associate editor for Annals of Allergy, Asthma, and Immunology and receives honoraria for that. He has received honoraria for speaking from the Canadian Society for Allergy and Clinical Immunology, Toledo Allergy Society Colorado Allergy Asthma Society, Lurie Children's Hospital, the American College of Allergy Asthma and Immunology, and the Allergy and Asthma Network. He has received honoraria for consulting for Deerfield Industries, bioIndustries, and Huron Consulting. He is an unpaid medical advisory board member to the Kids with Food Allergies Foundation, the International Association for Food Protein Enterocolitis, the Food Allergy & Anaphylaxis Connection Team (medical advisory board chair), and is a member of the Scientific Advisory Council for the National Peanut Board. He has provided expert testimony on behalf of epinephrine and restaurant food allergy awareness bills to the Michigan State Legislature. He has no other conflicts of interest relevant to this work. The rest of the authors declare that they have no relevant conflicts of interest.
Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2007/8
Y1 - 2007/8
N2 - Context. - There have been 2 putative prostatic cancer precursors, prostatic intraepithelial neoplasia (PIN) and atypical adenomatous hyperplasia (adenosis), but PIN remains as a well-known precancerous condition. Objective. - To describe recent advances in knowledge of PIN and to better define the diagnostic criteria and differential diagnosis of PIN. Data Sources. - Review of the pertinent literature and our experience. Conclusions. - The presence of ductal/acinar epithelial changes including nuclear enlargement, prominent nucleoli, chromatin alterations, and luminal complexity is an easy way to identify the disorder. Four main patterns of high-grade PIN (HGPIN) have been described: tufting, micropapillary, cribriform, and flat. In addition, variants of HGPIN have also been described. Both HGPIN and prostatic carcinoma share an increased incidence and severity with advancing age and with high rates of occurrence in the peripheral zone of the prostate. Furthermore, HGPIN and prostate cancer share genetic and molecular markers as well, with PIN representing an intermediate stage between benign epithelium and invasive carcinoma. The clinical significance of HGPIN is that it identifies patients at risk for prostatic carcinoma. With the increased use of extended biopsy protocols, clinicians are more likely to identify HGPIN and less likely to miss concurrent carcinoma.
AB - Context. - There have been 2 putative prostatic cancer precursors, prostatic intraepithelial neoplasia (PIN) and atypical adenomatous hyperplasia (adenosis), but PIN remains as a well-known precancerous condition. Objective. - To describe recent advances in knowledge of PIN and to better define the diagnostic criteria and differential diagnosis of PIN. Data Sources. - Review of the pertinent literature and our experience. Conclusions. - The presence of ductal/acinar epithelial changes including nuclear enlargement, prominent nucleoli, chromatin alterations, and luminal complexity is an easy way to identify the disorder. Four main patterns of high-grade PIN (HGPIN) have been described: tufting, micropapillary, cribriform, and flat. In addition, variants of HGPIN have also been described. Both HGPIN and prostatic carcinoma share an increased incidence and severity with advancing age and with high rates of occurrence in the peripheral zone of the prostate. Furthermore, HGPIN and prostate cancer share genetic and molecular markers as well, with PIN representing an intermediate stage between benign epithelium and invasive carcinoma. The clinical significance of HGPIN is that it identifies patients at risk for prostatic carcinoma. With the increased use of extended biopsy protocols, clinicians are more likely to identify HGPIN and less likely to miss concurrent carcinoma.
UR - http://www.scopus.com/inward/record.url?scp=34547917581&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=34547917581&partnerID=8YFLogxK
M3 - Review article
C2 - 17683188
AN - SCOPUS:34547917581
VL - 131
SP - 1257
EP - 1266
JO - Archives of Pathology and Laboratory Medicine
JF - Archives of Pathology and Laboratory Medicine
SN - 0003-9985
IS - 8
ER -